SlideShare a Scribd company logo
Genomics Solutions
Single Target to Whole Genome Analysis
With applied genomics expertise, transformative investments, global co-location with the #1
Central Labs provider and unmatched solutions from biomarker discovery to CDx, we’ll help
you make your Precision Medicine a reality, faster.
Applied genomics expertise
from single target to whole genome analysis for exploratory
and regulated testing across a broad range of platforms
Transformative investments
globally deliver scale, scope and innovation today and in the future
Global co-location with the #1 Provider
of Central Labs, logistics and specimen management services
Unmatched solutions from biomarker discovery
to CDx via personalized biomarker support to help drive your
development from bench to commercialization
Comprehensive Applications:
Gene Expression
Multiple tools for PD biomarkers
▶ Whole genome - microarray or NGS
▶ Targeted panels - RT-qPCR, nanoString, NGS
miRNA
Novel biomarkers for disease monitoring
▶ Whole genome - microarray, RT-qPCR, NGS
▶ Targeted panels - Exiqon or TaqMan
Genotyping
Predictive biomarkers
▶ Detailed genome or exome analysis
▶ Targeted panels - qPCR and ddPCR
Methylation
Multiple approaches for Epigenetics
▶ High-level surveys reveal patterns
▶ High-resolution analysis defines important regions
PGx
Known and Novel ADME markers
▶ Multiplexed panels - microarray, NGS
▶ Targeted panels - qPCR/OpenArray, microarray
Mutational Testing
Tumor Classification
▶ Pathway focused panels
▶ Targeted mutations - KRAS, BRAF, TP53, etc.
CNV
Reveal Dosage Imbalances
▶ Whole genome - microarray
▶ Targeted panels - qPCR, ddPCR, nanoString
BioBanking
Confidence in Sample Stability
▶ Sample characterization
▶ Multiple location options
Scientific Areas of Focus
Liquid Biopsies
▶ NGS analysis of CTCs and cfDNA
Immuno-Oncology
▶ Gene expression for autoimmune diseases
▶ Complementary approaches for immune
function profiling
Tumor Mutational Burden
▶ Whole exome sequencing
▶ Focused cancer gene panels
Microbiome
▶ 16S sequencing
▶ Whole genome sequencing
Innovations Advancing Precision Medicine Through
Cutting-Edge Science
Single-Cell Genomics Analysis
Resolve the complexities of disease biology
heterogeneity
Immune Profile Elucidation
Improved predictive performance for I/O therapies
Non-Invasive Biomarkers in
NASH
Applications of genotyping in drug development
Novel Assays
To advance therapies for rare and orphan diseases
Transformative Investments and Enhancements
Indianapolis Shanghai
Geneva Singapore
▶ New, 16K ft2
flagship lab
co-located with Central Labs
▶ Consolidates exploratory studies
and biomarker development,
patient management (CAP/CLIA)
laboratory testing and
CDx development
▶ New, state-of-the-art Aland
Center facility
▶ Genomics, Central Labs, APH,
Microbiology  Immunology
▶ ~90% increase in genomics
laboratory footprint
▶ Diversified testing
▶ Next-generation sequencing
(NGS) platforms installation
▶ Expected completion in
early 2020
The Central Laboratory, Redefined Exploratory Biomarkers to CDx
▶ Whole genome analysis, onsite
▶ Translational biomarker solutions
▶ Advanced specialty testing capabilities
▶ Access to LabCorp Specialty Testing
Group labs
▶ Assay development and transfer
▶ Clinical trial assays under
Design Control
▶ Verification and Validation
▶ Regulatory support and
commercialization
Learn more about our drug development solutions at www.covance.com
Covance is a business segment of LabCorp, a leading global life sciences company, which provides contract research
services to the drug, medical device and diagnostic, crop protection and chemical industries. COVANCE is a
registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.
www.covance.com
© Copyright 2020 Covance Inc. SSGENO001-0220

More Related Content

What's hot

Digital transformation of translational medicine
Digital transformation of translational medicineDigital transformation of translational medicine
Digital transformation of translational medicine
Eagle Genomics
 
Considerations and challenges in building an end to-end microbiome workflow
Considerations and challenges in building an end to-end microbiome workflowConsiderations and challenges in building an end to-end microbiome workflow
Considerations and challenges in building an end to-end microbiome workflow
Eagle Genomics
 
Scientific Comprehension of Cell Line Development Strategy Based on the CHOZN...
Scientific Comprehension of Cell Line Development Strategy Based on the CHOZN...Scientific Comprehension of Cell Line Development Strategy Based on the CHOZN...
Scientific Comprehension of Cell Line Development Strategy Based on the CHOZN...
Merck Life Sciences
 
Patient Centricity: EHR Pillars to Patient Centricity
Patient Centricity: EHR Pillars to Patient CentricityPatient Centricity: EHR Pillars to Patient Centricity
Patient Centricity: EHR Pillars to Patient Centricity
DayOne
 
Validating microbiome claims – including the latest DNA techniques
Validating microbiome claims – including the latest DNA techniquesValidating microbiome claims – including the latest DNA techniques
Validating microbiome claims – including the latest DNA techniques
Eagle Genomics
 
Introduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator ModelIntroduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator Model
Drew Hertig, MBA, CLP
 
Pistoia Alliance USA Conference 2016
Pistoia Alliance USA Conference 2016Pistoia Alliance USA Conference 2016
Pistoia Alliance USA Conference 2016
Pistoia Alliance
 
Pistoia Alliance US Conference 2015 - 1.3.2 New member introductions - DNAnexus
Pistoia Alliance US Conference 2015 - 1.3.2 New member introductions - DNAnexusPistoia Alliance US Conference 2015 - 1.3.2 New member introductions - DNAnexus
Pistoia Alliance US Conference 2015 - 1.3.2 New member introductions - DNAnexus
Pistoia Alliance
 
VSWarehouse; a scalable, rapid genomic repository solution
VSWarehouse; a scalable, rapid genomic repository solutionVSWarehouse; a scalable, rapid genomic repository solution
VSWarehouse; a scalable, rapid genomic repository solution
Golden Helix
 
Real-Time Data. Real-World Impact.
Real-Time Data. Real-World Impact.Real-Time Data. Real-World Impact.
Real-Time Data. Real-World Impact.
Covance
 
ADCs, A Highly Targeted Drug Therapy For Cancer
ADCs, A Highly Targeted Drug Therapy For CancerADCs, A Highly Targeted Drug Therapy For Cancer
ADCs, A Highly Targeted Drug Therapy For Cancer
DoriaFang
 
Expert Panel on Data Challenges in Translational Research
Expert Panel on Data Challenges in Translational ResearchExpert Panel on Data Challenges in Translational Research
Expert Panel on Data Challenges in Translational Research
Eagle Genomics
 
DayOne Experts - Next generation clinical trials
DayOne Experts - Next generation clinical trialsDayOne Experts - Next generation clinical trials
DayOne Experts - Next generation clinical trials
DayOne
 
ScienceCloud: Collaborative Workflows in Biologics R&D
ScienceCloud: Collaborative Workflows in Biologics R&DScienceCloud: Collaborative Workflows in Biologics R&D
ScienceCloud: Collaborative Workflows in Biologics R&D
BIOVIA
 
Performing a Trio Analysis in VSClinical
Performing a Trio Analysis in VSClinicalPerforming a Trio Analysis in VSClinical
Performing a Trio Analysis in VSClinical
Golden Helix
 
rev_2 (1) (3)
rev_2 (1) (3)rev_2 (1) (3)
rev_2 (1) (3)
Deepak Chandrasekaran
 
Biomarker Analyst_Presentation_For_Client
Biomarker Analyst_Presentation_For_ClientBiomarker Analyst_Presentation_For_Client
Biomarker Analyst_Presentation_For_Client
Camille Diges
 
Using the CDD Vault for MM4TB
Using the CDD Vault for MM4TBUsing the CDD Vault for MM4TB
Using the CDD Vault for MM4TB
Sean Ekins
 
Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...
Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...
Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...
L.E.K. Consulting
 
Structure-Based Drug Design Facts & Figures Infographic
Structure-Based Drug Design Facts & Figures InfographicStructure-Based Drug Design Facts & Figures Infographic
Structure-Based Drug Design Facts & Figures Infographic
James Prudhomme
 

What's hot (20)

Digital transformation of translational medicine
Digital transformation of translational medicineDigital transformation of translational medicine
Digital transformation of translational medicine
 
Considerations and challenges in building an end to-end microbiome workflow
Considerations and challenges in building an end to-end microbiome workflowConsiderations and challenges in building an end to-end microbiome workflow
Considerations and challenges in building an end to-end microbiome workflow
 
Scientific Comprehension of Cell Line Development Strategy Based on the CHOZN...
Scientific Comprehension of Cell Line Development Strategy Based on the CHOZN...Scientific Comprehension of Cell Line Development Strategy Based on the CHOZN...
Scientific Comprehension of Cell Line Development Strategy Based on the CHOZN...
 
Patient Centricity: EHR Pillars to Patient Centricity
Patient Centricity: EHR Pillars to Patient CentricityPatient Centricity: EHR Pillars to Patient Centricity
Patient Centricity: EHR Pillars to Patient Centricity
 
Validating microbiome claims – including the latest DNA techniques
Validating microbiome claims – including the latest DNA techniquesValidating microbiome claims – including the latest DNA techniques
Validating microbiome claims – including the latest DNA techniques
 
Introduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator ModelIntroduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator Model
 
Pistoia Alliance USA Conference 2016
Pistoia Alliance USA Conference 2016Pistoia Alliance USA Conference 2016
Pistoia Alliance USA Conference 2016
 
Pistoia Alliance US Conference 2015 - 1.3.2 New member introductions - DNAnexus
Pistoia Alliance US Conference 2015 - 1.3.2 New member introductions - DNAnexusPistoia Alliance US Conference 2015 - 1.3.2 New member introductions - DNAnexus
Pistoia Alliance US Conference 2015 - 1.3.2 New member introductions - DNAnexus
 
VSWarehouse; a scalable, rapid genomic repository solution
VSWarehouse; a scalable, rapid genomic repository solutionVSWarehouse; a scalable, rapid genomic repository solution
VSWarehouse; a scalable, rapid genomic repository solution
 
Real-Time Data. Real-World Impact.
Real-Time Data. Real-World Impact.Real-Time Data. Real-World Impact.
Real-Time Data. Real-World Impact.
 
ADCs, A Highly Targeted Drug Therapy For Cancer
ADCs, A Highly Targeted Drug Therapy For CancerADCs, A Highly Targeted Drug Therapy For Cancer
ADCs, A Highly Targeted Drug Therapy For Cancer
 
Expert Panel on Data Challenges in Translational Research
Expert Panel on Data Challenges in Translational ResearchExpert Panel on Data Challenges in Translational Research
Expert Panel on Data Challenges in Translational Research
 
DayOne Experts - Next generation clinical trials
DayOne Experts - Next generation clinical trialsDayOne Experts - Next generation clinical trials
DayOne Experts - Next generation clinical trials
 
ScienceCloud: Collaborative Workflows in Biologics R&D
ScienceCloud: Collaborative Workflows in Biologics R&DScienceCloud: Collaborative Workflows in Biologics R&D
ScienceCloud: Collaborative Workflows in Biologics R&D
 
Performing a Trio Analysis in VSClinical
Performing a Trio Analysis in VSClinicalPerforming a Trio Analysis in VSClinical
Performing a Trio Analysis in VSClinical
 
rev_2 (1) (3)
rev_2 (1) (3)rev_2 (1) (3)
rev_2 (1) (3)
 
Biomarker Analyst_Presentation_For_Client
Biomarker Analyst_Presentation_For_ClientBiomarker Analyst_Presentation_For_Client
Biomarker Analyst_Presentation_For_Client
 
Using the CDD Vault for MM4TB
Using the CDD Vault for MM4TBUsing the CDD Vault for MM4TB
Using the CDD Vault for MM4TB
 
Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...
Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...
Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...
 
Structure-Based Drug Design Facts & Figures Infographic
Structure-Based Drug Design Facts & Figures InfographicStructure-Based Drug Design Facts & Figures Infographic
Structure-Based Drug Design Facts & Figures Infographic
 

Similar to Genomics Solutions - Single Target to Whole Genome Analysis

Open Frame Sequencing™
Open Frame Sequencing™ Open Frame Sequencing™
Open Frame Sequencing™
INVICTA GENETICS
 
Next Generation Companion Diagnostics; Adoption, Drivers, and Moderators of N...
Next Generation Companion Diagnostics; Adoption, Drivers, and Moderators of N...Next Generation Companion Diagnostics; Adoption, Drivers, and Moderators of N...
Next Generation Companion Diagnostics; Adoption, Drivers, and Moderators of N...
Andrew Aijian
 
NGS for Infectious Disease Diagnostics: An Opportunity for Growth
NGS for Infectious Disease Diagnostics: An Opportunity for Growth NGS for Infectious Disease Diagnostics: An Opportunity for Growth
NGS for Infectious Disease Diagnostics: An Opportunity for Growth
Alira Health
 
Novel Molecular techniques.pptx
Novel Molecular techniques.pptxNovel Molecular techniques.pptx
Novel Molecular techniques.pptx
IbrahimAboAlasaad
 
Oncogenomics 2013
Oncogenomics 2013Oncogenomics 2013
Oncogenomics 2013
Elsa von Licy
 
The Application of Next Generation Sequencing (NGS) in cancer treatment
The Application of Next Generation Sequencing (NGS) in cancer treatmentThe Application of Next Generation Sequencing (NGS) in cancer treatment
The Application of Next Generation Sequencing (NGS) in cancer treatment
Premadarshini Sai
 
Clinical genomics spx
Clinical genomics   spxClinical genomics   spx
Clinical genomics spx
Diane McKenna
 
Optimizing the Output of Your Molecular Pathology Laboratory
Optimizing the Output of Your Molecular Pathology LaboratoryOptimizing the Output of Your Molecular Pathology Laboratory
Optimizing the Output of Your Molecular Pathology Laboratory
Josh Forsythe
 
Personalized Medicine through Tumor Sequencing
Personalized Medicine through Tumor SequencingPersonalized Medicine through Tumor Sequencing
Personalized Medicine through Tumor Sequencing
Golden Helix Inc
 
Personalized Medicine Through Tumor Sequencing
Personalized Medicine Through Tumor SequencingPersonalized Medicine Through Tumor Sequencing
Personalized Medicine Through Tumor Sequencing
Golden Helix
 
Ashg presentation 2010
Ashg presentation 2010Ashg presentation 2010
Ashg presentation 2010
Oxford Gene Technology
 
Axt microarrays
Axt microarraysAxt microarrays
Axt microarrays
Heidi Barrier
 
Targos_Company_Brochure_lowres
Targos_Company_Brochure_lowresTargos_Company_Brochure_lowres
Targos_Company_Brochure_lowres
Targos Inc, San Bruno, California
 
Targos_Company_Brochure_lowres
Targos_Company_Brochure_lowresTargos_Company_Brochure_lowres
Targos_Company_Brochure_lowres
Targos Inc, San Bruno, California
 
Precision Medicine- Growth Opportunities for Genomics Technologies
Precision Medicine- Growth Opportunities for Genomics TechnologiesPrecision Medicine- Growth Opportunities for Genomics Technologies
Precision Medicine- Growth Opportunities for Genomics Technologies
William Baird
 
STEMVAC_Consortium management case_Dr. Sandra Huygen
STEMVAC_Consortium management case_Dr. Sandra HuygenSTEMVAC_Consortium management case_Dr. Sandra Huygen
STEMVAC_Consortium management case_Dr. Sandra Huygen
Sandra HUYGEN
 
Novellus DX
Novellus DXNovellus DX
Oncology Drug Development Solutions
Oncology Drug Development SolutionsOncology Drug Development Solutions
Oncology Drug Development Solutions
Covance
 
Ed Millensted - 100,00 Genomes Project
Ed Millensted - 100,00 Genomes ProjectEd Millensted - 100,00 Genomes Project
Ed Millensted - 100,00 Genomes Project
Innovation Agency
 
Translating Genomes | Personalizing Medicine
Translating Genomes | Personalizing MedicineTranslating Genomes | Personalizing Medicine
Translating Genomes | Personalizing Medicine
Candy Smellie
 

Similar to Genomics Solutions - Single Target to Whole Genome Analysis (20)

Open Frame Sequencing™
Open Frame Sequencing™ Open Frame Sequencing™
Open Frame Sequencing™
 
Next Generation Companion Diagnostics; Adoption, Drivers, and Moderators of N...
Next Generation Companion Diagnostics; Adoption, Drivers, and Moderators of N...Next Generation Companion Diagnostics; Adoption, Drivers, and Moderators of N...
Next Generation Companion Diagnostics; Adoption, Drivers, and Moderators of N...
 
NGS for Infectious Disease Diagnostics: An Opportunity for Growth
NGS for Infectious Disease Diagnostics: An Opportunity for Growth NGS for Infectious Disease Diagnostics: An Opportunity for Growth
NGS for Infectious Disease Diagnostics: An Opportunity for Growth
 
Novel Molecular techniques.pptx
Novel Molecular techniques.pptxNovel Molecular techniques.pptx
Novel Molecular techniques.pptx
 
Oncogenomics 2013
Oncogenomics 2013Oncogenomics 2013
Oncogenomics 2013
 
The Application of Next Generation Sequencing (NGS) in cancer treatment
The Application of Next Generation Sequencing (NGS) in cancer treatmentThe Application of Next Generation Sequencing (NGS) in cancer treatment
The Application of Next Generation Sequencing (NGS) in cancer treatment
 
Clinical genomics spx
Clinical genomics   spxClinical genomics   spx
Clinical genomics spx
 
Optimizing the Output of Your Molecular Pathology Laboratory
Optimizing the Output of Your Molecular Pathology LaboratoryOptimizing the Output of Your Molecular Pathology Laboratory
Optimizing the Output of Your Molecular Pathology Laboratory
 
Personalized Medicine through Tumor Sequencing
Personalized Medicine through Tumor SequencingPersonalized Medicine through Tumor Sequencing
Personalized Medicine through Tumor Sequencing
 
Personalized Medicine Through Tumor Sequencing
Personalized Medicine Through Tumor SequencingPersonalized Medicine Through Tumor Sequencing
Personalized Medicine Through Tumor Sequencing
 
Ashg presentation 2010
Ashg presentation 2010Ashg presentation 2010
Ashg presentation 2010
 
Axt microarrays
Axt microarraysAxt microarrays
Axt microarrays
 
Targos_Company_Brochure_lowres
Targos_Company_Brochure_lowresTargos_Company_Brochure_lowres
Targos_Company_Brochure_lowres
 
Targos_Company_Brochure_lowres
Targos_Company_Brochure_lowresTargos_Company_Brochure_lowres
Targos_Company_Brochure_lowres
 
Precision Medicine- Growth Opportunities for Genomics Technologies
Precision Medicine- Growth Opportunities for Genomics TechnologiesPrecision Medicine- Growth Opportunities for Genomics Technologies
Precision Medicine- Growth Opportunities for Genomics Technologies
 
STEMVAC_Consortium management case_Dr. Sandra Huygen
STEMVAC_Consortium management case_Dr. Sandra HuygenSTEMVAC_Consortium management case_Dr. Sandra Huygen
STEMVAC_Consortium management case_Dr. Sandra Huygen
 
Novellus DX
Novellus DXNovellus DX
Novellus DX
 
Oncology Drug Development Solutions
Oncology Drug Development SolutionsOncology Drug Development Solutions
Oncology Drug Development Solutions
 
Ed Millensted - 100,00 Genomes Project
Ed Millensted - 100,00 Genomes ProjectEd Millensted - 100,00 Genomes Project
Ed Millensted - 100,00 Genomes Project
 
Translating Genomes | Personalizing Medicine
Translating Genomes | Personalizing MedicineTranslating Genomes | Personalizing Medicine
Translating Genomes | Personalizing Medicine
 

More from Covance

Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Covance
 
Pharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for BiosimilarsPharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for Biosimilars
Covance
 
Cell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval Solutions
Covance
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise Solutions
Covance
 
Cell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development SolutionsCell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development Solutions
Covance
 
Inhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory TreatmentsInhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory Treatments
Covance
 
Covance Laboratory FSPx Solutions
Covance Laboratory FSPx SolutionsCovance Laboratory FSPx Solutions
Covance Laboratory FSPx Solutions
Covance
 
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
Covance
 
Environmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical DrugsEnvironmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical Drugs
Covance
 
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Covance
 
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric ProgramPutting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
Covance
 
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty MarketTop 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Covance
 
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Covance
 
Covance Phase IV Solutions Brochure
Covance Phase IV Solutions BrochureCovance Phase IV Solutions Brochure
Covance Phase IV Solutions Brochure
Covance
 
Optimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access ExperienceOptimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access Experience
Covance
 
Patient Safety Cloud Solution Brochure
Patient Safety Cloud Solution BrochurePatient Safety Cloud Solution Brochure
Patient Safety Cloud Solution Brochure
Covance
 
Plant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant CultivationPlant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant Cultivation
Covance
 
Biocide Authorization Timeline
Biocide Authorization TimelineBiocide Authorization Timeline
Biocide Authorization Timeline
Covance
 
K-REACH - How to Prepare for the K-REACH Legislation
K-REACH - How to Prepare for the K-REACH LegislationK-REACH - How to Prepare for the K-REACH Legislation
K-REACH - How to Prepare for the K-REACH Legislation
Covance
 
US Toxic Substances Control Act (TSCA) Reform
US Toxic Substances Control Act (TSCA) ReformUS Toxic Substances Control Act (TSCA) Reform
US Toxic Substances Control Act (TSCA) Reform
Covance
 

More from Covance (20)

Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
 
Pharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for BiosimilarsPharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for Biosimilars
 
Cell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval Solutions
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise Solutions
 
Cell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development SolutionsCell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development Solutions
 
Inhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory TreatmentsInhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory Treatments
 
Covance Laboratory FSPx Solutions
Covance Laboratory FSPx SolutionsCovance Laboratory FSPx Solutions
Covance Laboratory FSPx Solutions
 
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
 
Environmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical DrugsEnvironmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical Drugs
 
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
 
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric ProgramPutting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
 
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty MarketTop 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
 
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
 
Covance Phase IV Solutions Brochure
Covance Phase IV Solutions BrochureCovance Phase IV Solutions Brochure
Covance Phase IV Solutions Brochure
 
Optimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access ExperienceOptimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access Experience
 
Patient Safety Cloud Solution Brochure
Patient Safety Cloud Solution BrochurePatient Safety Cloud Solution Brochure
Patient Safety Cloud Solution Brochure
 
Plant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant CultivationPlant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant Cultivation
 
Biocide Authorization Timeline
Biocide Authorization TimelineBiocide Authorization Timeline
Biocide Authorization Timeline
 
K-REACH - How to Prepare for the K-REACH Legislation
K-REACH - How to Prepare for the K-REACH LegislationK-REACH - How to Prepare for the K-REACH Legislation
K-REACH - How to Prepare for the K-REACH Legislation
 
US Toxic Substances Control Act (TSCA) Reform
US Toxic Substances Control Act (TSCA) ReformUS Toxic Substances Control Act (TSCA) Reform
US Toxic Substances Control Act (TSCA) Reform
 

Recently uploaded

Anatomy, and reproduction of Gnetum.pptx
Anatomy, and reproduction of Gnetum.pptxAnatomy, and reproduction of Gnetum.pptx
Anatomy, and reproduction of Gnetum.pptx
karthiksaran8
 
Adjusted NuGOweek 2024 Ghent programme flyer
Adjusted NuGOweek 2024 Ghent programme flyerAdjusted NuGOweek 2024 Ghent programme flyer
Adjusted NuGOweek 2024 Ghent programme flyer
pablovgd
 
Probing the northern Kaapvaal craton root with mantle-derived xenocrysts from...
Probing the northern Kaapvaal craton root with mantle-derived xenocrysts from...Probing the northern Kaapvaal craton root with mantle-derived xenocrysts from...
Probing the northern Kaapvaal craton root with mantle-derived xenocrysts from...
James AH Campbell
 
Direct instructions, towards hundred fold yield,layering,budding,grafting,pla...
Direct instructions, towards hundred fold yield,layering,budding,grafting,pla...Direct instructions, towards hundred fold yield,layering,budding,grafting,pla...
Direct instructions, towards hundred fold yield,layering,budding,grafting,pla...
Dr. sreeremya S
 
Introduction to Space (Our Solar System)
Introduction to Space (Our Solar System)Introduction to Space (Our Solar System)
Introduction to Space (Our Solar System)
vanshgarg8002
 
How Does TaskTrain Integrate Workflow and Project Management Efficiently.pdf
How Does TaskTrain Integrate Workflow and Project Management Efficiently.pdfHow Does TaskTrain Integrate Workflow and Project Management Efficiently.pdf
How Does TaskTrain Integrate Workflow and Project Management Efficiently.pdf
Task Train
 
The cryptoterrestrial hypothesis: A case for scientific openness to a conceal...
The cryptoterrestrial hypothesis: A case for scientific openness to a conceal...The cryptoterrestrial hypothesis: A case for scientific openness to a conceal...
The cryptoterrestrial hypothesis: A case for scientific openness to a conceal...
Sérgio Sacani
 
BIOPHYSICS Interactions of molecules in 3-D space-determining binding and.pptx
BIOPHYSICS Interactions of molecules in 3-D space-determining binding and.pptxBIOPHYSICS Interactions of molecules in 3-D space-determining binding and.pptx
BIOPHYSICS Interactions of molecules in 3-D space-determining binding and.pptx
alishyt102010
 
seed drying lecture, different types of dryers
seed drying lecture, different types of dryersseed drying lecture, different types of dryers
seed drying lecture, different types of dryers
Rammehargahlot1
 
LOB LOD LOQ for method validation in laboratory
LOB LOD LOQ for method validation in laboratoryLOB LOD LOQ for method validation in laboratory
LOB LOD LOQ for method validation in laboratory
JCKH
 
Simulations of pulsed overpressure jets: formation of bellows and ripples in ...
Simulations of pulsed overpressure jets: formation of bellows and ripples in ...Simulations of pulsed overpressure jets: formation of bellows and ripples in ...
Simulations of pulsed overpressure jets: formation of bellows and ripples in ...
Sérgio Sacani
 
morphology and reproduction of Thuja.pptx
morphology and reproduction of Thuja.pptxmorphology and reproduction of Thuja.pptx
morphology and reproduction of Thuja.pptx
karthiksaran8
 
20240710 ACMJ Diagrams Set 3.docx . Apache, Csharp, Mysql, Javascript stack a...
20240710 ACMJ Diagrams Set 3.docx . Apache, Csharp, Mysql, Javascript stack a...20240710 ACMJ Diagrams Set 3.docx . Apache, Csharp, Mysql, Javascript stack a...
20240710 ACMJ Diagrams Set 3.docx . Apache, Csharp, Mysql, Javascript stack a...
Sharon Liu
 
Lunar Mobility Drivers and Needs - Artemis
Lunar Mobility Drivers and Needs - ArtemisLunar Mobility Drivers and Needs - Artemis
Lunar Mobility Drivers and Needs - Artemis
Sérgio Sacani
 
Detection of the elusive dangling OH ice features at ~2.7 μm in Chamaeleon I ...
Detection of the elusive dangling OH ice features at ~2.7 μm in Chamaeleon I ...Detection of the elusive dangling OH ice features at ~2.7 μm in Chamaeleon I ...
Detection of the elusive dangling OH ice features at ~2.7 μm in Chamaeleon I ...
Sérgio Sacani
 
smallintestinedisorders-causessymptoms-240626042532-363e8392.pptx
smallintestinedisorders-causessymptoms-240626042532-363e8392.pptxsmallintestinedisorders-causessymptoms-240626042532-363e8392.pptx
smallintestinedisorders-causessymptoms-240626042532-363e8392.pptx
muralinath2
 
Modelling, Simulation, and Computer-aided Design in Computational, Evolutiona...
Modelling, Simulation, and Computer-aided Design in Computational, Evolutiona...Modelling, Simulation, and Computer-aided Design in Computational, Evolutiona...
Modelling, Simulation, and Computer-aided Design in Computational, Evolutiona...
University of Maribor
 
Bragg Brentano Alignment for D4 with LynxEye Rev3.pptx
Bragg Brentano Alignment for D4 with LynxEye Rev3.pptxBragg Brentano Alignment for D4 with LynxEye Rev3.pptx
Bragg Brentano Alignment for D4 with LynxEye Rev3.pptx
Lisandro Cunci
 
poikilocytosis 23765437865210857453257844.pptx
poikilocytosis 23765437865210857453257844.pptxpoikilocytosis 23765437865210857453257844.pptx
poikilocytosis 23765437865210857453257844.pptx
muralinath2
 
Possible Anthropogenic Contributions to the LAMP-observed Surficial Icy Regol...
Possible Anthropogenic Contributions to the LAMP-observed Surficial Icy Regol...Possible Anthropogenic Contributions to the LAMP-observed Surficial Icy Regol...
Possible Anthropogenic Contributions to the LAMP-observed Surficial Icy Regol...
Sérgio Sacani
 

Recently uploaded (20)

Anatomy, and reproduction of Gnetum.pptx
Anatomy, and reproduction of Gnetum.pptxAnatomy, and reproduction of Gnetum.pptx
Anatomy, and reproduction of Gnetum.pptx
 
Adjusted NuGOweek 2024 Ghent programme flyer
Adjusted NuGOweek 2024 Ghent programme flyerAdjusted NuGOweek 2024 Ghent programme flyer
Adjusted NuGOweek 2024 Ghent programme flyer
 
Probing the northern Kaapvaal craton root with mantle-derived xenocrysts from...
Probing the northern Kaapvaal craton root with mantle-derived xenocrysts from...Probing the northern Kaapvaal craton root with mantle-derived xenocrysts from...
Probing the northern Kaapvaal craton root with mantle-derived xenocrysts from...
 
Direct instructions, towards hundred fold yield,layering,budding,grafting,pla...
Direct instructions, towards hundred fold yield,layering,budding,grafting,pla...Direct instructions, towards hundred fold yield,layering,budding,grafting,pla...
Direct instructions, towards hundred fold yield,layering,budding,grafting,pla...
 
Introduction to Space (Our Solar System)
Introduction to Space (Our Solar System)Introduction to Space (Our Solar System)
Introduction to Space (Our Solar System)
 
How Does TaskTrain Integrate Workflow and Project Management Efficiently.pdf
How Does TaskTrain Integrate Workflow and Project Management Efficiently.pdfHow Does TaskTrain Integrate Workflow and Project Management Efficiently.pdf
How Does TaskTrain Integrate Workflow and Project Management Efficiently.pdf
 
The cryptoterrestrial hypothesis: A case for scientific openness to a conceal...
The cryptoterrestrial hypothesis: A case for scientific openness to a conceal...The cryptoterrestrial hypothesis: A case for scientific openness to a conceal...
The cryptoterrestrial hypothesis: A case for scientific openness to a conceal...
 
BIOPHYSICS Interactions of molecules in 3-D space-determining binding and.pptx
BIOPHYSICS Interactions of molecules in 3-D space-determining binding and.pptxBIOPHYSICS Interactions of molecules in 3-D space-determining binding and.pptx
BIOPHYSICS Interactions of molecules in 3-D space-determining binding and.pptx
 
seed drying lecture, different types of dryers
seed drying lecture, different types of dryersseed drying lecture, different types of dryers
seed drying lecture, different types of dryers
 
LOB LOD LOQ for method validation in laboratory
LOB LOD LOQ for method validation in laboratoryLOB LOD LOQ for method validation in laboratory
LOB LOD LOQ for method validation in laboratory
 
Simulations of pulsed overpressure jets: formation of bellows and ripples in ...
Simulations of pulsed overpressure jets: formation of bellows and ripples in ...Simulations of pulsed overpressure jets: formation of bellows and ripples in ...
Simulations of pulsed overpressure jets: formation of bellows and ripples in ...
 
morphology and reproduction of Thuja.pptx
morphology and reproduction of Thuja.pptxmorphology and reproduction of Thuja.pptx
morphology and reproduction of Thuja.pptx
 
20240710 ACMJ Diagrams Set 3.docx . Apache, Csharp, Mysql, Javascript stack a...
20240710 ACMJ Diagrams Set 3.docx . Apache, Csharp, Mysql, Javascript stack a...20240710 ACMJ Diagrams Set 3.docx . Apache, Csharp, Mysql, Javascript stack a...
20240710 ACMJ Diagrams Set 3.docx . Apache, Csharp, Mysql, Javascript stack a...
 
Lunar Mobility Drivers and Needs - Artemis
Lunar Mobility Drivers and Needs - ArtemisLunar Mobility Drivers and Needs - Artemis
Lunar Mobility Drivers and Needs - Artemis
 
Detection of the elusive dangling OH ice features at ~2.7 μm in Chamaeleon I ...
Detection of the elusive dangling OH ice features at ~2.7 μm in Chamaeleon I ...Detection of the elusive dangling OH ice features at ~2.7 μm in Chamaeleon I ...
Detection of the elusive dangling OH ice features at ~2.7 μm in Chamaeleon I ...
 
smallintestinedisorders-causessymptoms-240626042532-363e8392.pptx
smallintestinedisorders-causessymptoms-240626042532-363e8392.pptxsmallintestinedisorders-causessymptoms-240626042532-363e8392.pptx
smallintestinedisorders-causessymptoms-240626042532-363e8392.pptx
 
Modelling, Simulation, and Computer-aided Design in Computational, Evolutiona...
Modelling, Simulation, and Computer-aided Design in Computational, Evolutiona...Modelling, Simulation, and Computer-aided Design in Computational, Evolutiona...
Modelling, Simulation, and Computer-aided Design in Computational, Evolutiona...
 
Bragg Brentano Alignment for D4 with LynxEye Rev3.pptx
Bragg Brentano Alignment for D4 with LynxEye Rev3.pptxBragg Brentano Alignment for D4 with LynxEye Rev3.pptx
Bragg Brentano Alignment for D4 with LynxEye Rev3.pptx
 
poikilocytosis 23765437865210857453257844.pptx
poikilocytosis 23765437865210857453257844.pptxpoikilocytosis 23765437865210857453257844.pptx
poikilocytosis 23765437865210857453257844.pptx
 
Possible Anthropogenic Contributions to the LAMP-observed Surficial Icy Regol...
Possible Anthropogenic Contributions to the LAMP-observed Surficial Icy Regol...Possible Anthropogenic Contributions to the LAMP-observed Surficial Icy Regol...
Possible Anthropogenic Contributions to the LAMP-observed Surficial Icy Regol...
 

Genomics Solutions - Single Target to Whole Genome Analysis

  • 1. Genomics Solutions Single Target to Whole Genome Analysis With applied genomics expertise, transformative investments, global co-location with the #1 Central Labs provider and unmatched solutions from biomarker discovery to CDx, we’ll help you make your Precision Medicine a reality, faster. Applied genomics expertise from single target to whole genome analysis for exploratory and regulated testing across a broad range of platforms Transformative investments globally deliver scale, scope and innovation today and in the future Global co-location with the #1 Provider of Central Labs, logistics and specimen management services Unmatched solutions from biomarker discovery to CDx via personalized biomarker support to help drive your development from bench to commercialization Comprehensive Applications: Gene Expression Multiple tools for PD biomarkers ▶ Whole genome - microarray or NGS ▶ Targeted panels - RT-qPCR, nanoString, NGS miRNA Novel biomarkers for disease monitoring ▶ Whole genome - microarray, RT-qPCR, NGS ▶ Targeted panels - Exiqon or TaqMan Genotyping Predictive biomarkers ▶ Detailed genome or exome analysis ▶ Targeted panels - qPCR and ddPCR Methylation Multiple approaches for Epigenetics ▶ High-level surveys reveal patterns ▶ High-resolution analysis defines important regions PGx Known and Novel ADME markers ▶ Multiplexed panels - microarray, NGS ▶ Targeted panels - qPCR/OpenArray, microarray Mutational Testing Tumor Classification ▶ Pathway focused panels ▶ Targeted mutations - KRAS, BRAF, TP53, etc. CNV Reveal Dosage Imbalances ▶ Whole genome - microarray ▶ Targeted panels - qPCR, ddPCR, nanoString BioBanking Confidence in Sample Stability ▶ Sample characterization ▶ Multiple location options
  • 2. Scientific Areas of Focus Liquid Biopsies ▶ NGS analysis of CTCs and cfDNA Immuno-Oncology ▶ Gene expression for autoimmune diseases ▶ Complementary approaches for immune function profiling Tumor Mutational Burden ▶ Whole exome sequencing ▶ Focused cancer gene panels Microbiome ▶ 16S sequencing ▶ Whole genome sequencing Innovations Advancing Precision Medicine Through Cutting-Edge Science Single-Cell Genomics Analysis Resolve the complexities of disease biology heterogeneity Immune Profile Elucidation Improved predictive performance for I/O therapies Non-Invasive Biomarkers in NASH Applications of genotyping in drug development Novel Assays To advance therapies for rare and orphan diseases Transformative Investments and Enhancements Indianapolis Shanghai Geneva Singapore ▶ New, 16K ft2 flagship lab co-located with Central Labs ▶ Consolidates exploratory studies and biomarker development, patient management (CAP/CLIA) laboratory testing and CDx development ▶ New, state-of-the-art Aland Center facility ▶ Genomics, Central Labs, APH, Microbiology Immunology ▶ ~90% increase in genomics laboratory footprint ▶ Diversified testing ▶ Next-generation sequencing (NGS) platforms installation ▶ Expected completion in early 2020 The Central Laboratory, Redefined Exploratory Biomarkers to CDx ▶ Whole genome analysis, onsite ▶ Translational biomarker solutions ▶ Advanced specialty testing capabilities ▶ Access to LabCorp Specialty Testing Group labs ▶ Assay development and transfer ▶ Clinical trial assays under Design Control ▶ Verification and Validation ▶ Regulatory support and commercialization Learn more about our drug development solutions at www.covance.com Covance is a business segment of LabCorp, a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostic, crop protection and chemical industries. COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world. www.covance.com © Copyright 2020 Covance Inc. SSGENO001-0220